blocking agents of the adrenoceptors alpha 1/alpha 2 are typically used to treat the effects of the vasoconstriction associated with vascular claudication. cilostazol (trade name: pletal) is fda approved for intermittent claudication. it is contraindicated in patients with heart failure, and improvement of symptoms may not be evident for two to three weeks.